Sökning: onr:"swepub:oai:DiVA.org:uu-533106" > Patient-reported Si...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 07991naa a2200673 4500 | |
001 | oai:DiVA.org:uu-533106 | |
003 | SwePub | |
008 | 240625s2024 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:umu-223032 | |
009 | oai:lup.lub.lu.se:ae76ad2e-73c8-401a-adae-ee145996bc66 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5331062 URI |
024 | 7 | a https://doi.org/10.1016/j.euo.2023.12.0072 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2230322 URI |
024 | 7 | a https://lup.lub.lu.se/record/ae76ad2e-73c8-401a-adae-ee145996bc662 URI |
040 | a (SwePub)uud (SwePub)umud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Corsini, Christianu Uppsala University,Uppsala universitet,Institutionen för kirurgiska vetenskaper,IRCCS San Raffaele Hosp, Urol Res Inst, Div Expt Oncol, Unit Urol, Milan, Italy.,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy4 aut |
245 | 1 0 | a Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer :b A Register-based Nationwide Study |
264 | 1 | b Elsevier,c 2024 |
338 | a print2 rdacarrier | |
520 | a Background: Data on functional and psychological side effects following curative treatment for prostate cancer are lacking from large, contemporary, unselected, populationbased cohorts. Objective: To assess urinary symptoms, bowel disturbances, erectile dysfunction (ED), and quality of life (QoL) 12 mo after robot -assisted radical prostatectomy (RARP) and radiotherapy (RT) using patient -reported outcome measures in the Swedish prostate cancer database. Design, setting, and participants: This was a nationwide, population -based, cohort study in Sweden of men who underwent primary RARP or RT between January 1, 2018 and December 31, 2020. Outcome measurements and statistical analysis: Absolute proportions and odds ratios (ORs) were calculated using multivariable logistic regression, with adjustment for clinical characteristics. Results and limitations: A total of 2557 men underwent RARP and 1741 received RT. Men who underwent RT were older (69 vs 65 yr) and had more comorbidities at baseline. After RARP, 13% of men experienced incontinence, compared to 6% after RT. The frequency of urinary bother was similar, at 18% after RARP and 18% after RT. Urgency to defecate was reported by 14% of men after RARP and 34% after RT. At 1 yr, 73% of men had ED after RARP, and 77% after RT. High QoL was reported by 85% of men after RARP and 78% of men after RT. On multivariable regression analysis, RT was associated with lower risks of urinary incontinence (OR 0.25, 95% confidence interval [CI] 0.19- 0.33), urinary bother (OR 0.79, 95% CI 0.66-0.95), and ED (OR 0.54, 95% CI 0.46-0.65), but higher risk of bowel symptoms (OR 2.86, 95% CI 2.42-3.39). QoL was higher after RARP than after RT (OR 1.34, 95% CI 1.12-1.61). Conclusions: Short-term specific side effects after curative treatment for prostate cancer significantly differed between RARP and RT in this large and unselected cohort. Nevertheless, the risk of urinary bother was lower after RT, while higher QoL was common after RARP. Patient summary: In our study of patients treated for prostate cancer, urinary bother and overall quality of life are comparable at 1 year after surgical removal of the prostate in comparison to radiotherapy, despite substantial differences in other side effects. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Omvårdnad0 (SwePub)303052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nursing0 (SwePub)303052 hsv//eng |
653 | a Prostate cancer | |
653 | a Radical prostatectomy | |
653 | a Radiotherapy | |
653 | a Patient-reported outcomes | |
653 | a Population-based study | |
653 | a Patient-reported outcomes | |
653 | a Population-based study | |
653 | a Prostate cancer | |
653 | a Radical prostatectomy | |
653 | a Radiotherapy | |
700 | 1 | a Bergengren, Oskaru Uppsala University,Uppsala universitet,Urologkirurgi,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden4 aut0 (Swepub:uu)oskka588 |
700 | 1 | a Carlsson, Stefanu Karolinska Univ Hosp, Dept Urol, Solna, Sweden.,Department of Urology, Karolinska University Hospital, Solna, Sweden4 aut |
700 | 1 | a Garmo, Hansu Uppsala University,Uppsala universitet,Urologkirurgi,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden4 aut0 (Swepub:uu)hga27600 |
700 | 1 | a Hjelm-Eriksson, Marieu St Goran Hosp, Dept Oncol, Stockholm, Sweden.,Department of Oncology, St. Göran Hospital, Stockholm, Sweden,Capio St. Görans Sjukhus4 aut |
700 | 1 | a Fransson, Peru Umeå University,Umeå universitet,Institutionen för omvårdnad,Cancercentrum, Norrlands University Hospital, Umeå, Sweden,Umeå Univ, Dept Nursing, Umeå, Sweden.;Norrlands Univ Hosp, Canc Ctr, Umeå, Sweden.4 aut0 (Swepub:umu)perfrn96 |
700 | 1 | a Kindblom, Jonu Univ Gothenburg, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden.,Department of Oncology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden4 aut |
700 | 1 | a Robinson, Davidu Ryhov Hosp, Dept Urol, Jönköping, Sweden.,Department of Urology, Ryhov Hospital, Jönköping, Sweden,Ryhov County Hospital, Jönköping4 aut |
700 | 1 | a Westerberg, Marcus,d 1990-u Uppsala University,Uppsala universitet,Urologkirurgi,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden4 aut0 (Swepub:uu)marwe776 |
700 | 1 | a Stattin, Päru Uppsala University,Uppsala universitet,Urologkirurgi,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden4 aut0 (Swepub:uu)parst892 |
700 | 1 | a Carlsson, Sigrid V.u University of Gothenburg,Lund University,Lunds universitet,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Urological cancer, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Memorial Sloan-Kettering Cancer Center,Mem Sloan Kettering Canc Ctr, Dept Surg Urol Serv, 1133 York Ave, New York, NY 10065 USA.;Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA.;Gothenburg Univ, Sahlgrenska Acad, Dept Urol, Gothenburg, Sweden.;Lund Univ, Med Fac, Dept Translat Med, Div Urol Canc, Lund, Sweden.4 aut0 (Swepub:lu)si5270ca |
710 | 2 | a Uppsala universitetb Institutionen för kirurgiska vetenskaper4 org |
773 | 0 | t European Urology Oncologyd : Elsevierg 7:3, s. 605-613q 7:3<605-613x 2588-9311 |
856 | 4 | u https://doi.org/10.1016/j.euo.2023.12.007y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1849699/FULLTEXT02.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u http://dx.doi.org/10.1016/j.euo.2023.12.007x freey FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-533106 |
856 | 4 8 | u https://doi.org/10.1016/j.euo.2023.12.007 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-223032 |
856 | 4 8 | u https://lup.lub.lu.se/record/ae76ad2e-73c8-401a-adae-ee145996bc66 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.